Side areas

orphanix

Medical Technology/Digital Health 2015

orphanix

Abstract:
orphanix is a virtual pharmaceutical start-up that develops drug therapies for neglected and rare diseases, so-called "orphan diseases". In this way, we complement the drug portfolios of fully integrated, internationally active pharmaceutical companies that are active or intend to become active in the field of rare diseases.

Products:
Drug therapies for rare diseases in accordance with the valid "Orphan Drug/ Orphan Medicinal Product Regulations" in the respective countries.

Facts

CEO
Dr.Philipp Novak
Project start: 2015
Industry: Pharma/ Orphan Diseases ( Seltene Erkrankungen)
Employees: 1
Markets: International pharmaceutical companies focusing on rare diseases and commercial activities in the following countries: European Economic Area, USA, Japan, Singapore, UAE, South Korea, Saudi Arabia
orphanix
Peter Roseggerstrasse 41
4910 Ried im Innkreis
WordPress Cookie Plugin by Real Cookie Banner